Article info
Multiple sclerosis
Original research
Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosis
- Correspondence to Dr Manuel Comabella, Neurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia, Vall d'Hebron University Hospital, Barcelona 08035, Spain; manuel.comabella{at}vhir.org
Citation
Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosis
Publication history
- Received August 17, 2022
- Accepted October 14, 2022
- First published November 7, 2022.
Online issue publication
May 17, 2023
Article Versions
- Previous version (14 February 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.